Fundz

Fundz Deep Dive

Everything you need to win Douglas Gladue — in one platform.

Who to reach, what to say, and why now on Douglas Gladue — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Douglas Gladue — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Seek Labs Appoints Dr. Douglas Gladue As Vice President of Veterinary Pharmaceutical Development

PRIVATEJun 03, 2024•about 2 years ago

Position

Vice President

Company

Seek Labs

Douglas Gladue
Salt Lake CityBiotechnology

Description

Seek Labs is pleased to announce the appointment of Dr Douglas Gladue, PhD as the new Vice President of Veterinary Pharmaceutical Development. Dr Gladue, an internationally recognized expert in African Swine Fever (ASF) research and development, brings decades of knowledge and experience in ASF vaccine research and development to Seek Labs where he will lead research and development efforts in CRISPR-based veterinary pharmaceutical projects.

Company Information

Company

Seek Labs

Location

350 W 800 N

Salt Lake City, Utah, United States

About

Seek Labs is united by a vision to advance scientific discovery and universal solutions. We strive to innovate healthcare solutions that bridge gaps between patients, providers, and treatments. At Seek Labs, we want to empower humanity by increasing access to diagnostic and pharmaceutical solutions. We foster a culture of dynamic, result-oriented teamwork that yields revolutionary innovations and employees. We are looking for talented and driven individuals to join us in research, regulatory, clinical, operations, testing, manufacturing, marketing, and business positions. Ready to be part of the future of infectious disease diagnostics and pharmaceuticals? Please reach out to us today.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Seek Labs's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.